SCHEMBL6726280

SCHEMBL6726280

O=C(O)c1c[nH]c2ccc(OCCCN3CCC3)nc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 2/20 0.46
PRKAB2 O43741 4/20 0.43
PRKAG1 P54619 4/20 0.43
PRKAA2 P54646 4/20 0.43
PRKAA1 Q13131 4/20 0.43
PRKAG3 Q9UGI9 4/20 0.43
PRKAG2 Q9UGJ0 4/20 0.43
PRKAB1 Q9Y478 4/20 0.43
ALDH1A1 P00352 5/20 0.41
KDM4E B2RXH2 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MAPT P10636 2/20 0.41
POLB P06746 1/20 0.41
PARP1 P09874 1/20 0.41
HRH3 Q9Y5N1 2/20 0.40
KCNH2 Q12809 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6726432 0.97 DHODH (0.49) DHODHPRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL6724501 0.92 ALDH1A1 (0.46) DHODHPRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL6724740 0.91 PRKAB2 (0.52) DHODHPRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL6726264 0.90 PRKAB2 (0.53) DHODHPRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL6726653 0.87 KDM4E (0.52) ALDH1A1KDM4ESMN1; SMN2HRH3
SCHEMBL6724521 0.85 PRKAB2 (0.46) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL6722255 0.84 PRKAB2 (0.52) DHODHPRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL6733358 0.84 PRKAB2 (0.37) DHODHPRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL6734018 0.81 MET (0.51) ALDH1A1KDM4ESMN1; SMN2CYP1A2CYP2D6
SCHEMBL6734639 0.80 HRH3 (0.41) HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6673811-B1 TREATMENT OF ANXIETY, DEPRESSION, SLEEP DISORDER, ATTENTION DEFICIT DISORDER, ALZHEIMER'S DEMENTIA, OR SHORT-TERM MEMORY LOSS NEUROGEN CORPORATION 2004-01-06 US claimed
US-6673811-B1 TREATMENT OF ANXIETY, DEPRESSION, SLEEP DISORDER, ATTENTION DEFICIT DISORDER, ALZHEIMER'S DEMENTIA, OR SHORT-TERM MEMORY LOSS NEUROGEN CORPORATION 2004-01-06 US disclosed